SFARI Explorer Awards

Sponsor:

Simons Foundation Autism Research Initiative (SFARI)

Deadline:

Applications are considered on a rolling basis, with a response time as early as 30 days.

Summary:

This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.

Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.

Eligibility:

All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.

Available Funding:

The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.

Link to Full RFP:

https://sfari.org/funding/grants/explorer-awards-rfa

SFARI Bridge to Independence Award Request for Applications

Sponsor:

Simons Foundation Autism Research Initiative (SFARI)

Deadline:

August 7, 2017

Summary:

The Simons Foundation Autism Research Initiative (SFARI) seeks to improve the understanding, diagnosis and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.  In order to sustain this level of scientific excellence in future years, SFARI is extending our support to promising early-career investigators.

Grants awarded through the Bridge to Independence Award program are intended to invest in the next generation of top autism investigators by identifying talented early-career scientists interested in autism research and facilitating their transition to an independent research career. This request for applications (RFA) is aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the 2017–18 academic year. Successful applicants will be notified that they are finalists in the Bridge to Independence Award program and will have one year to submit an approval application, which includes confirmation of a tenure-track professorship at a U.S. academic institution, review of the institution’s research environment and resources, and institutional signoff.

Eligibility:

  • Applicants must hold a Ph.D., M.D. or equivalent degree
  • Applicants must have fewer than six (6) years of postdoctoral or otherwise mentored training.
  • Applicants must be currently in non-independent, mentored, training positions, as recognized by their institution. The following guidelines should be used to distinguish independent from non-independent positions (modified from NIH’s K99/R00 Program Announcement eligibility section): Evidence for non-independence may include:
  • The applicant’s research is entirely funded by another investigator’s grants.
  • The applicant’s research is conducted entirely in another investigator’s assigned space.
  • According to institutional policy, the applicant is not allowed to submit an application for an NIH research grant (e.g., R01) or SFARI grant (e.g, Explorer, Pilot, Research, and Targeted awards.)
  • Applicants must be actively seeking a tenure-track position at a U.S. institution of higher education during 2017-18 academic year.
  • Applicants are not eligible if they are recipients of other career development awards with similar budgetary scope as the SFARI Bridge to Independence award. These include, but are not limited to:
    • NIH K99/R00 (please note that other K awardees may be eligible, e.g., K01 and K08)
    • Burroughs-Wellcome Fund Career Award for Medical Scientists
    • American Academy of Neurology Career Development Award
    • Howard Hughes Medical Institute Hanna H. Gray fellowship

You are strongly encouraged to contact SFARI prior to grant submission if you believe your career development award is comparable to the BTI award but is not listed above.

  • Applicants must not have accepted a formal offer for a tenure-track faculty position.
  • There are no citizenship requirements.

Available Funding:

The principal investigator (PI) will receive research support at a fixed rate of $150,000 per year, including 20 percent for indirect costs (see SFARI policies), for up to three (3) years. Funds may not be used toward the PI’s salary but may provide salary support for other laboratory personnel. Institutional start-up packages may not be reduced because of SFARI funding.

Link to Full RFP:

https://sfari.org/funding/grants/bridge-to-independence-rfa/bridge-to-independence-award-request-for-applications

Multi-discipline and Systemic Caring for the Woman Experiencing Menopause: Innovative Decision Making Tools

Sponsor:

Pfizer Independent Grants for Learning & Change

Deadline:

July 12, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to support optimal and/or appropriate practice interventions regarding care and treatment of women experiencing menopause. Projects should focus on educational resources (e.g. patient-physician shared decision-making tools /innovative apps) to support effective identification of the need for therapeutic intervention and appropriate selection of therapeutic intervention based on presentation.

  • The learning and change strategy should address helping improve the care of women with menopause by:
  • Improving symptom identification (by patients or physicians)
  • Improving care systems that showcase and operationalize the wellness visit as a focus for menopausal care

Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment The educational initiative should be focused on primary care practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and all other specialists who care for the menopausal woman. Proposals whose educational model is broadly applicable for use in other settings and/or used for resident education will be rated favorably.

In addition, proposals that include the following elements are of interest:

  • Completed within a 12 month timeframe
  • Developing durable tools, materials (e.g. >1 one time use)
  • Intraprofessional collaboration among organizations
  • Incorporating the patient perspective
  • Innovative in terms of approach and output
  • Robust outcomes plan that reflects optimization of care metrics

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.

Projects that focus on live annual meetings, regional conferences, and speaker series are out of scope.

Eligibility:

Project  must be based in the United States.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH2_MenopausalCare.v.2.pdf

Addressing Attitudes, Beliefs, and Cultural Barriers in Women’s Health Decision-Making

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 26, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to understand the role of patient attitudes, beliefs, and cultural barriers in women’s health decision-making during reproductive and post-reproductive health care. These factors have a major influence and variations exist globally for women during life events including family planning and menopause related issues. The learning and change strategy should address techniques to overcome barriers in improving the care of women during family planning and/or menopause by:

  • Improving care systems that showcase and operationalize the wellness visit
  • Innovating the patient-physician dialogue (e.g. ‘difficult conversations’)
  • Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment
  • Dispelling common patient myths and misconceptions.

The educational initiative should be focused on primary care practitioners including general practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and/or other specialists who care for women in the reproductive phase of their lives, menopausal women, or all. Proposals whose educational model is broadly applicable for use in varied settings and/or used for trainee education will be rated favorably.

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.  

Eligibility:

Project must be global in scope.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH1_WomensHealth.v.2.pdf

Clinical Trial Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required): July 20, 2017

Application (by invitation only): October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proofof-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of the military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required.

Eligibility:

  • PIs at or above the level of Assistant Professor (or equivalent) are eligible to submit applications.
  • Funding from this award mechanism must support a clinical trial. Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Funding limit not defined; requested funding must be appropriate for the scope of work proposed/Maximum period of performance is 4 years

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-CTA.pdf

Discovery Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 19, 2017

Application (by invitation only):  August 2, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The intent of the PRMRP Discovery Award is to support innovative, non-incremental, highrisk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a wellformulated, testable hypothesis based on a sound scientific rationale and study design.

The outcome of research supported by this award should be the generation of preliminary data that can be used as a foundation for future research projects to understand the mechanisms of initiation or progression and/or improving patient care for a disease or condition.

Eligibility:

  • Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above are eligible to submit applications.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Maximum of $200,000 for direct costs (plus indirect costs)/ Maximum period of performance is 18 months

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-DA.pdf

Focused Program Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 20, 2017

Application (by invitation only):  October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas. The PRMRP Focused Program Award mechanism is intended to optimize research and accelerate the solution for a critical question.

  • Projects must support a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal.
  • Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
  • Projects may range from exploratory/ hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.
  • Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.

Eligibility:

  • The PI must be an independent investigator at or above the level of Full Professor (or equivalent).
  • The PI is required to devote a minimum of 20% effort to this award.
  • Project leaders for each of the complementary and synergistic research projects must be at or above the level of Assistant Professor (or equivalent).
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

The anticipated total costs budgeted for the entire period of performance will not exceed $10M / maximum period of performance is 4 years.

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-FPA.pdf

POST-DOCTORAL TRAINING SUPPORT PROGRAM IN CLINICAL AND TRANSLATIONAL RESEARCH (TL1)

Sponsor:

Clinical and Translational Science Institute (CTSI)

Deadline:

5PM on June 27, 2017

Summary:

The TL1 offers support, mentoring and training opportunities for late-stage pre-doctoral and early-stage post-doctoral scholars conducting research in the area of health care and/or translational medicine. The program provides stipends, training and mentoring while emphasizing the scholar’s success within their established research area. The fundamental goal of the program is to help and support scholars as they advance in their research careers, and to provide them with the knowledge and skills to eventually develop into successful, independent researchers. The program encourages productivity, collaborative research and career development.

Eligibility:

Late-stage pre-doctoral PhD students who have completed required coursework, as well as early stage post-doctoral research scholars (1-2 years after completion of pre-doctoral training) are eligible to apply. Post-doctoral scholars should be actively engaged in translationally-relevant research. Scholars from any unit or school in the University, or with appointments at CTSI-affiliated New York City Health + Hospitals institutions, are eligible to apply. Applicants must have the support of their research advisor/mentor.

Available Funding:

The TL1 program will provide up to two years of stipend and other support. Based on NIH requirements, the stipend for pre-doctoral candidates will be set at a maximum of $22,920 annually. For post-doctoral scholars, salary will be set at NIH post-graduate year levels (See NIH website: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-048.html). Additional funds will be available for educational courses and travel to meetings. Pre-doctoral scholars who graduate, or post-doctoral scholars who successfully compete for an NIH K or R award or equivalent, will be rotated off the program.

Link to Full RFP:

https://med.nyu.edu/ctsi/training-education/research-career-development/tl1

Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp) (PA-17-286)

Sponsor:

National Institutes of Health

Deadline:

June 30, 2017

Summary:

The purpose of the administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program.  The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic). Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation. Prospective applicants are strongly encouraged to contact NIH Scientific/Research staff for more information about the program before applying.

 Eligibility:

Participating Institutes:

  • National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • National Heart, Lung, and Blood Institute (NHLBI)

Additional funds may be awarded as supplements to parent awards from the Institutes above using the following Activity Code(s):

  • P01 Research Program Projects
  • P41 Biotechnology Resource Grants
  • R01 Research Project Grant
  • R24 Resource-Related Research Projects
  • R41/R42 Small Business Technology Transfer (STTR) Grant – Phase I, Phase II, and Fast-Track
  • R43/R44 Small Business Innovation Research (SBIR) Grant – Phase I, Phase II, and Fast-Track
  • U01 Research Project – Cooperative Agreements
  • U44 Small Business Innovation Research (SBIR) Cooperative Agreements – Phase II
  • UG3/UH3 Exploratory/Developmental Phased Award Cooperative Agreement
  • UH2/UH3 Phase Innovation Awards Cooperative Agreement

Available Funding:

NIH intends to commit up to $500,000 in direct costs in FY 2017 to fund 24 awards.

Application budgets are limited to no more than $30,000 in direct costs for SBIR/STTR parent awards (R41, R42, R43, R44, U44) and $18,000 in direct costs for other parent awards (P01, P41, R01, R24, U01, UG3, UH2, UH3). The award budget should only be used to cover costs associated with participation in the C3i Program.

Link to Full RFP:

https://grants.nih.gov/grants/guide/pa-files/PA-17-286.html

LIMITED COMPETITION: Helen Hay Whitney Foundation Postdoctoral Research Fellowship

Sponsor:

Helen Hay Whitney Foundation

Deadline:

5 PM EST, June 30, 2017

Summary:

To attain its ultimate goal of increasing the number of imaginative, well-trained and dedicated medical scientists, the Foundation grants financial support of sufficient duration to help further the careers of young men and women engaged in biological or medical research.

Eligibility:

The SAC will review no more than one application from a laboratory during each annual cycle. We will accept applications from different laboratories/supervisors at the same institution. Should we receive more than one, the Chair of the SAC will decide which of the applications appears most competitive and decline the other(s) administratively. We urge the heads of laboratories to make this choice for us, if at all possible. 

  • The Foundation will not ordinarily consider applicants who plan tenure of the fellowship in the laboratory in which they have already received extensive predoctoral or postdoctoral training. The aim of the fellowship is to broaden postdoctoral training and experience, and a significant change of venue is advisable.
  • Candidates who hold, or are in the final stages of obtaining a Ph.D., M.D., or equivalent degree and are seeking beginning postdoctoral training in basic biomedical research are eligible to apply for a fellowship.
  • The Foundation accepts applications from candidates who have no more than one year of postdoctoral research experience at the time of the deadline for submitting the application (June 30, 2017), and who have received a PhD (or D.Phil. or equivalent) degree no more than two years before the deadline, or an M.D. degree no more than three years before the deadline.
  • Fellowships may be awarded to US citizens planning to work in laboratories either in the US, Canada, or abroad and also to foreign citizens for research in laboratories in the US only. We expect that most applicants will reside in North America at the time of application. Foreign Students will need to obtain appropriate visa documentation, as required by US Immigration.

Available Funding:

 The fellowship is for 3 years and includes an annual stipend (starting at $52,000) plus an annual research allowance of $1,500. There is a also a Dependent Child Allowance of $1,500 per annum for each child.

Link to Full RFP:

Research Fellowship